menu
    • menu

    Company profile for Biophytis

    NEW Drugs in Dev: 3
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We are a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, with a primary focus on neuromuscular diseases. Our goal is to become a leader in the emerging field of aging science by delivering life-changing therapies to the growing number of patients in need t...
    We are a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases, with a primary focus on neuromuscular diseases. Our goal is to become a leader in the emerging field of aging science by delivering life-changing therapies to the growing number of patients in need that have limited or no treatment options. To accomplish this goal, we have assembled an experienced and skilled group of industry professionals, scientists, clinicians and key opinion leaders from leading industry

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BiophytisFrance Flag
    Country
    Country
    France
    Address
    Address
    Sorbonne Université Bâtiment A 4 ème étage 4 place Jussieu – 75252 Paris...
    Telephone
    Telephone
    +33 1 44 27 23 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.biophytis.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/biophytis
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/biophytis

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biophytis-Lynxkite Boosts AI Drug Discovery for Next-Generation
    Biophytis-Lynxkite Boosts AI Drug Discovery for Next-Generation

    13 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biophytis-lynxkite-alliance-expands-to-turbocharge-ai-driven-drug-discovery-for-next-generation-longevity-therapeutics-302713532.html

    PR NEWSWIRE
    13 Mar 2026
    Share Share
    Biophytis Expands Asian Presence With Two Local Agent Contracts
    Biophytis Expands Asian Presence With Two Local Agent Contracts

    23 Jul 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=171435&sid=2

    PHARMABIZ
    23 Jul 2024
    Share Share
    Biophytis Gets FDA IND Approval For Phase 2 OBA Obesity Study
    Biophytis Gets FDA IND Approval For Phase 2 OBA Obesity Study

    10 Jul 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=887710&lang=en

    ACCESSWIRE
    10 Jul 2024
    Share Share
    Biophytis Presented its Ph 2-3 COVA Study Results in Severe Forms of Covid-19
    Biophytis Presented its Ph 2-3 COVA Study Results in Severe Forms of Covid-19

    01 Jul 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=883739&lang=en

    ACCESSWIRE
    01 Jul 2024
    Share Share
    Biophytis Extends Contract With Atlas For Business Financing
    Biophytis Extends Contract With Atlas For Business Financing

    19 Jun 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=879420&lang=en

    ACCESSWIRE
    19 Jun 2024
    Share Share
    Biophytis Announces Successful BIO101 Indus. trial Transfer To Seqens
    Biophytis Announces Successful BIO101 Indus. trial Transfer To Seqens

    12 Jun 2024

    // PRESS RELEASE

    https://www.biophytis.com/en/biophytis-announces-the-successful-industrial-transfer-of-bio101-20-hydroxyecdysone-production-by-its-service-provider-seqens/

    PRESS RELEASE
    12 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search